Multiple Sclerosis (MS) Drug Market

RECENT NEWS
Wall Street Journal  Jan 29  Comment 
Biogen Idec said its fourth-quarter profit nearly doubled, as its portfolio of multiple sclerosis treatments drove a 34% growth in revenue.
Wall Street Journal  Jan 29  Comment 
New York Times  Jan 24  Comment 
As a postdoctoral student working with Dr. Alick Isaacs in 1957, Dr. Lindenmann discovered interferon, the powerful antiviral substance used to treat some cancers, hepatitis C and multiple sclerosis.
New York Times  Jan 23  Comment 
As a postdoctoral student working with Dr. Alick Isaacs in 1957, Dr. Lindenmann discovered interferon, the powerful antiviral substance used to treat some cancers, hepatitis C and multiple sclerosis.
New York Times  Jan 20  Comment 
The court said the company could still benefit from patent protection for the multiple sclerosis drug, dealing a blow to makers of generic drugs.
GenEng News  Jan 20  Comment 
An international research team reports that a common gut microbe might curb the risk in women of developing multiple sclerosis. The scientists, from Australia and the Netherlands, published their study (“Helicobacter pylori infection as a...
Forbes  Jan 6  Comment 
The human papillomavirus (HPV) vaccine Gardasil is not linked to an increased risk of multiple sclerosis or any other similar central nervous system conditions, found a study published in JAMA today.
MedPage Today  Dec 29  Comment 
(MedPage Today) -- From vitamin D to an OTC drug for MS, here are the top headlines from 2014.
Forbes  Dec 29  Comment 
There's enormous interest within the IoT community about how precisely your foot lands each time you take a step. Footfall, more accurately your gait, says a lot about your current state of health, whether it is the onset of multiple sclerosis or...
New York Times  Dec 20  Comment 
For Michele Lisandrelli, who has multiple sclerosis, traveling the six and a half miles to see her 88-year-old mother has become increasingly difficult.
MedPage Today  Dec 12  Comment 
(MedPage Today) -- A revolution in diagnosis and subsequent monitoring.




 
TOP CONTRIBUTORS

Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki